ScreenerHero
XRNChiron Real Estate Inc.
NYSE · US · Real Estate · REIT - Healthcare Facilities · chironre.com
37.52USD-0.11%Mkt Cap: 496.57M $P/E: —

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Chiron Real Estate Inc. was establishe…

Industry Peers

REIT - Healthcare Facilities
Screen all
vs REIT - Healthcare Facilities
P/B
Avg
Div Yield
Lower
1M Perf
Avg
WELL
Welltower Inc.
$160.22BUSDP/E 109.6
VTR
Ventas, Inc.
$43.17BUSDP/E 161.5
OHI
Omega Healthcare Investors, Inc.
$14.87BUSDP/E 23.0
DOC
Healthpeak Properties, Inc.
$14.75BUSDP/E 66.9
CTRE
CareTrust REIT, Inc.
$9.53BUSDP/E 25.5
HR
Healthcare Realty Trust Incorporated
$7.07BUSD
AED
Aedifica NV/SA
$6.41BUSDP/E 6.1
CSH-UN
Chartwell Retirement Residences
$5.30BUSDP/E Infinity
SBRA
Sabra Health Care REIT, Inc.
$4.92BUSDP/E 31.0
NHI
National Health Investors, Inc.
$3.70BUSDP/E 24.6
COFB
Cofinimmo SA
$3.43BUSDP/E 15.5
PHP
Primary Health Properties Plc
$2.70BUSDP/E 13.7
MPT
Medical Properties Trust, Inc.
$2.76BUSD
DHC
Diversified Healthcare Trust
$2.25BUSD
LTC
LTC Properties, Inc.
$1.97BUSDP/E 15.1
SILA
Sila Realty Trust, Inc.
$1.68BUSDP/E 44.6
NHP
National Healthcare Properties, Inc.
$1.08BUSD
CPINV
Care Property Invest NV
$578.96MUSDP/E 8.3
UHT
Universal Health Realty Income Trust
$608.58MUSDP/E 34.3
CHCT
Community Healthcare Trust Incorporated
$522.29MUSDP/E 152.3
STRW
Strawberry Fields REIT, Inc.
$184.62MUSDP/E 21.5
Indicators:|

Key Statistics

Company
Market Cap496.57M $
Enterprise Value1.30B $
Revenue (TTM)151.53M $
Gross Profit115.06M $
Net Income (TTM)-5.84M $
Revenue/Share11.36 USD
Last Price37.52 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees30
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-24.52
PEG5.09
EV/EBITDA14.25
EV/Revenue8.60
P/S3.28
P/B1.32
EPS (TTM)-1.13
EPS (Forward)-1.53
52W Range
29.0578% of range39.93
52W High39.93 USD
52W Low29.05 USD
Profitability
Gross Margin77.91%
Oper. Margin23.35%
EBITDA Margin60.32%
Profit Margin-3.95%
ROE-1.14%
ROA-0.47%
Growth
Revenue Growth10.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF73.61M $
CapEx (TTM)81.69M $
FCF Margin64.27%
FCF Yield19.61%
Net Debt661.35M $
Net Debt/EBITDA7.24
Balance Sheet
Debt/Equity1.31
Current Ratio0.99
Quick Ratio0.78
Book Value/Sh28.42 USD
Cash/Share1.164 USD
Dividends
Fwd Div Rate5.730 USD
Trail. Div Rate3.370 USD
Div. Yield15.27%
5Y Avg Yield10.00%
Payout Ratio1114.29%
Ex-Div DateJul 20, 2026
Pay DateSep 18, 2026
Splits
Last Split1:5
Split DateSep 22, 2025
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)35.91 USD
Upside (mean)-4.3%
Target Range9.000 USD – 46.00 USD
$9.000-4.3% to mean$46.00
# Analysts8
Ownership
Shares Out.13.23M
Float12.30M
Insiders6.25%
Institutions67.74%
Short Interest
Short Ratio4.5d
Short % Float5.94%
Short % Out.5.60%
Shares Short741.68K
Short (prev mo.)595.28K
Technical
SMA 5035.60 (+5.4%)
SMA 20034.50 (+8.7%)
Beta1.14
S&P 52W Chg20.05%
Avg Vol (30d)113.27K
Avg Vol (10d)145.37K
Technical Indicators
RSI (14)61.6
MACD0.3566
MACD Signal0.2232
MACD Hist.+0.1334
BB Upper37.97 USD
BB Middle36.22 USD
BB Lower34.46 USD
BB Width9.68%
ATR (14)1.011 USD
Vol Ratio (20d)0.51x